Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
Recruiting
N/A
Interventional Study
Alzheimer Dementia
Alzheimer Disease
Delirium Confusional State
Encephalopathy
Cognitive Abnormality
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 60 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 30 (estimated)
- Sponsor
- Covenant Health, US · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine if utilizing the Quest AD-Detect blood test, while patient's are hospitalized for a cognitive diagnosis (such as delirium or encephalopathy), will result in an earlier diagnosis of underlying Alzheimer's disease.
* Will this blood test have the ability to distinguish between Alzheimer's disease and other causes of cognitive impairment in the inpatie…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Ages 60 to 90 years old
* No prior diagnosis of dementia
* Currently hospitalized with cognitive diagnosis, including but no limited to; delirium, encephalopathy, etc. thought to be secondary to a toxic/metabolic state
Exclusion Criteria:
* Age under 60 years
* Prior diagnos…
Contacts